Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Aberant Gene Expression in Human Prostatic Carcinoma

NCT00868803 is registered in ClinicalTrials.gov with Lahey Clinic as lead sponsor.

NCT NCT00868803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00868803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Aberant Gene Expression in Human Prostatic Carcinoma
Lead sponsor
Lahey Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 1995
Completion date
April 30, 2030
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer